Business Description
Onyx Biotec Ltd
ISIN : INE0WVU01018
Compare
Compare
Traded in other countries / regions
ONYX.India IPO Date
2024-11-22Description
Onyx Biotec Ltd is engaged in healthcare segment and offering Sterile Pharmaceutical products ,and acts as a pharmaceutical contract manufacturer. It offering products such as Sterile Water for Injections, Dry Powder Injections and Dry Syrup for India and overseas. Key revenue is generated from Sterile Water for Injections .
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.05 | |||||
| Equity-to-Asset | 0.34 | |||||
| Debt-to-Equity | 1.24 | |||||
| Debt-to-EBITDA | 3.66 | |||||
| Interest Coverage | 2.89 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.58 | |||||
| 9-Day RSI | 42.85 | |||||
| 14-Day RSI | 45.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.31 | |||||
| Quick Ratio | 0.91 | |||||
| Cash Ratio | 0.06 | |||||
| Days Inventory | 78.8 | |||||
| Days Sales Outstanding | 69.43 | |||||
| Days Payable | 105.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.5 | |||||
| Operating Margin % | 11.32 | |||||
| Net Margin % | 5.64 | |||||
| FCF Margin % | -3.17 | |||||
| ROE % | 14.07 | |||||
| ROA % | 4.56 | |||||
| ROIC % | 8 | |||||
| ROC (Joel Greenblatt) % | 11.82 | |||||
| ROCE % | 13.68 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 32.24 | |||||
| PE Ratio without NRI | 32.24 | |||||
| PS Ratio | 1.82 | |||||
| PB Ratio | 3.93 | |||||
| Price-to-Tangible-Book | 3.93 | |||||
| Price-to-Operating-Cash-Flow | 64.47 | |||||
| EV-to-EBIT | 20.89 | |||||
| EV-to-EBITDA | 15.31 | |||||
| EV-to-Revenue | 2.4 | |||||
| EV-to-FCF | -74.93 | |||||
| Price-to-Graham-Number | 2.37 | |||||
| Earnings Yield (Greenblatt) % | 4.79 | |||||
| FCF Yield % | -1.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Onyx Biotec Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 537.488 | ||
| EPS (TTM) (₹) | 1.672 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 45.05 | ||
| 14-Day ATR (₹) | 2.38001 | ||
| 20-Day SMA (₹) | 55.5475 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (₹) | 51 - 62.5 | ||
| Shares Outstanding (Mil) | 18.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Onyx Biotec Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Onyx Biotec Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Onyx Biotec Ltd Frequently Asked Questions
What is Onyx Biotec Ltd(NSE:ONYX)'s stock price today?
The current price of NSE:ONYX is ₹53.90. The 52 week high of NSE:ONYX is ₹62.50 and 52 week low is ₹51.00.
When is next earnings date of Onyx Biotec Ltd(NSE:ONYX)?
The next earnings date of Onyx Biotec Ltd(NSE:ONYX) is .
Does Onyx Biotec Ltd(NSE:ONYX) pay dividends? If so, how much?
Onyx Biotec Ltd(NSE:ONYX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers